Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcoholism | 12 | 2023 | 1973 | 2.250 |
Why?
|
| Ethanol | 13 | 2022 | 1324 | 1.680 |
Why?
|
| Residential Treatment | 2 | 2024 | 111 | 1.590 |
Why?
|
| Gyrus Cinguli | 5 | 2023 | 1115 | 1.110 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2021 | 1140 | 1.090 |
Why?
|
| Brain | 28 | 2023 | 27103 | 1.080 |
Why?
|
| Breathing Exercises | 3 | 2020 | 59 | 0.960 |
Why?
|
| Brain Chemistry | 4 | 2015 | 959 | 0.900 |
Why?
|
| Yoga | 4 | 2020 | 281 | 0.870 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2015 | 3768 | 0.800 |
Why?
|
| Thalamus | 3 | 2020 | 1044 | 0.790 |
Why?
|
| Frontal Lobe | 5 | 2014 | 1420 | 0.780 |
Why?
|
| Alcohol Drinking | 4 | 2023 | 4027 | 0.780 |
Why?
|
| Religion | 2 | 2022 | 372 | 0.780 |
Why?
|
| Sex Characteristics | 4 | 2020 | 2637 | 0.740 |
Why?
|
| Hospitals, Psychiatric | 1 | 2021 | 321 | 0.680 |
Why?
|
| Emotions | 4 | 2022 | 2738 | 0.650 |
Why?
|
| Impulsive Behavior | 4 | 2015 | 346 | 0.630 |
Why?
|
| Depressive Disorder, Major | 7 | 2020 | 4760 | 0.630 |
Why?
|
| Adolescent Development | 3 | 2014 | 282 | 0.630 |
Why?
|
| Anxiety | 7 | 2024 | 4571 | 0.570 |
Why?
|
| Adolescent Behavior | 2 | 2021 | 1186 | 0.560 |
Why?
|
| Phosphorus | 3 | 2008 | 336 | 0.560 |
Why?
|
| Drug Tolerance | 3 | 2004 | 367 | 0.520 |
Why?
|
| Marijuana Abuse | 4 | 2015 | 411 | 0.510 |
Why?
|
| Students | 2 | 2018 | 1741 | 0.510 |
Why?
|
| Substance-Related Disorders | 4 | 2022 | 4419 | 0.470 |
Why?
|
| Amnesia, Retrograde | 1 | 2014 | 19 | 0.470 |
Why?
|
| Alcohol-Induced Disorders | 1 | 2014 | 27 | 0.460 |
Why?
|
| Depression | 4 | 2024 | 8122 | 0.450 |
Why?
|
| Drinking Behavior | 1 | 2014 | 103 | 0.450 |
Why?
|
| Glutamic Acid | 3 | 2019 | 1176 | 0.450 |
Why?
|
| Universities | 1 | 2018 | 994 | 0.430 |
Why?
|
| Glutamine | 2 | 2019 | 577 | 0.430 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2012 | 13 | 0.420 |
Why?
|
| Adolescent | 25 | 2024 | 88305 | 0.410 |
Why?
|
| Septal Nuclei | 2 | 2023 | 85 | 0.380 |
Why?
|
| Animals, Newborn | 6 | 2004 | 2678 | 0.380 |
Why?
|
| Space Perception | 1 | 2014 | 465 | 0.380 |
Why?
|
| Amygdala | 6 | 2023 | 1353 | 0.370 |
Why?
|
| Stroop Test | 1 | 2010 | 71 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2023 | 36430 | 0.360 |
Why?
|
| Marijuana Smoking | 2 | 2011 | 258 | 0.350 |
Why?
|
| Inpatients | 1 | 2021 | 2548 | 0.340 |
Why?
|
| Facial Expression | 1 | 2014 | 508 | 0.340 |
Why?
|
| Nerve Net | 1 | 2022 | 2288 | 0.340 |
Why?
|
| Prefrontal Cortex | 5 | 2021 | 2219 | 0.330 |
Why?
|
| Aspartic Acid | 3 | 2019 | 576 | 0.330 |
Why?
|
| Aging | 9 | 2019 | 8704 | 0.330 |
Why?
|
| Cognition Disorders | 3 | 2015 | 3979 | 0.330 |
Why?
|
| Cannabis | 1 | 2015 | 440 | 0.320 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2008 | 29 | 0.320 |
Why?
|
| Young Adult | 20 | 2024 | 59196 | 0.310 |
Why?
|
| Cerebral Cortex | 5 | 2019 | 5776 | 0.310 |
Why?
|
| Male | 57 | 2024 | 360621 | 0.310 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2004 | 894 | 0.300 |
Why?
|
| Central Nervous System Depressants | 4 | 2002 | 164 | 0.290 |
Why?
|
| Female | 57 | 2024 | 392485 | 0.290 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2004 | 86 | 0.250 |
Why?
|
| Methadone | 2 | 2006 | 321 | 0.250 |
Why?
|
| GABA Agonists | 2 | 2004 | 105 | 0.250 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2011 | 952 | 0.250 |
Why?
|
| Basal Ganglia | 2 | 2004 | 554 | 0.240 |
Why?
|
| Brain Mapping | 6 | 2022 | 6626 | 0.240 |
Why?
|
| Humans | 55 | 2024 | 761326 | 0.230 |
Why?
|
| Heroin Dependence | 1 | 2004 | 172 | 0.220 |
Why?
|
| Relaxation | 1 | 2003 | 51 | 0.220 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2008 | 625 | 0.220 |
Why?
|
| Putamen | 1 | 2004 | 292 | 0.220 |
Why?
|
| Narcotics | 2 | 2007 | 336 | 0.220 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2004 | 448 | 0.220 |
Why?
|
| Corticosterone | 1 | 2004 | 305 | 0.210 |
Why?
|
| Decision Making | 2 | 2014 | 3929 | 0.210 |
Why?
|
| Receptors, GABA-A | 2 | 2004 | 623 | 0.210 |
Why?
|
| Energy Metabolism | 3 | 2019 | 2879 | 0.200 |
Why?
|
| S-Adenosylmethionine | 1 | 2003 | 218 | 0.200 |
Why?
|
| Hypothermia | 2 | 2001 | 188 | 0.190 |
Why?
|
| Verbal Learning | 2 | 2019 | 463 | 0.190 |
Why?
|
| Memory | 2 | 2022 | 2187 | 0.190 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2008 | 8997 | 0.190 |
Why?
|
| Hypnotics and Sedatives | 2 | 1999 | 1178 | 0.180 |
Why?
|
| Memory, Long-Term | 1 | 2020 | 59 | 0.180 |
Why?
|
| Hippocampus | 3 | 2019 | 3763 | 0.180 |
Why?
|
| Methylphenidate | 1 | 2004 | 488 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2004 | 8166 | 0.170 |
Why?
|
| Temporal Lobe | 4 | 2022 | 1695 | 0.170 |
Why?
|
| Neurobiology | 1 | 2020 | 137 | 0.170 |
Why?
|
| Atrophy | 2 | 2015 | 1632 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2008 | 1545 | 0.160 |
Why?
|
| Analysis of Variance | 6 | 2011 | 6231 | 0.160 |
Why?
|
| Cognition | 5 | 2014 | 6987 | 0.160 |
Why?
|
| Creatine | 3 | 2021 | 427 | 0.160 |
Why?
|
| Sexual Maturation | 1 | 2020 | 261 | 0.150 |
Why?
|
| Occipital Lobe | 1 | 2020 | 374 | 0.150 |
Why?
|
| Neuropsychological Tests | 5 | 2010 | 7045 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2007 | 2790 | 0.150 |
Why?
|
| Cocaine-Related Disorders | 3 | 2007 | 461 | 0.140 |
Why?
|
| Sleep | 3 | 2014 | 4765 | 0.140 |
Why?
|
| Limbic System | 1 | 2019 | 419 | 0.140 |
Why?
|
| Spirituality | 1 | 2021 | 425 | 0.140 |
Why?
|
| Rats | 12 | 2020 | 23729 | 0.140 |
Why?
|
| Adult | 25 | 2022 | 221122 | 0.130 |
Why?
|
| Blood Volume | 2 | 2008 | 548 | 0.130 |
Why?
|
| Central Nervous System Stimulants | 1 | 2004 | 1176 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2021 | 4579 | 0.130 |
Why?
|
| Age Factors | 7 | 2012 | 18401 | 0.130 |
Why?
|
| Regional Blood Flow | 4 | 2008 | 1495 | 0.120 |
Why?
|
| Gender Identity | 1 | 2020 | 766 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2004 | 10764 | 0.120 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 462 | 0.120 |
Why?
|
| Models, Animal | 2 | 2020 | 2112 | 0.120 |
Why?
|
| Synaptic Transmission | 2 | 2014 | 1172 | 0.110 |
Why?
|
| Imagination | 1 | 2014 | 226 | 0.110 |
Why?
|
| Phosphocreatine | 2 | 2004 | 261 | 0.110 |
Why?
|
| Motor Activity | 4 | 2014 | 2710 | 0.110 |
Why?
|
| Child | 8 | 2015 | 80156 | 0.110 |
Why?
|
| Sex Factors | 6 | 2021 | 10551 | 0.110 |
Why?
|
| Respiration | 1 | 2019 | 1657 | 0.110 |
Why?
|
| Maze Learning | 1 | 2014 | 482 | 0.100 |
Why?
|
| Psychotherapy | 1 | 2021 | 1647 | 0.100 |
Why?
|
| Case-Control Studies | 5 | 2021 | 22124 | 0.100 |
Why?
|
| Regression Analysis | 3 | 2014 | 6341 | 0.100 |
Why?
|
| Risk Factors | 6 | 2022 | 74152 | 0.100 |
Why?
|
| Risk | 1 | 2004 | 9605 | 0.100 |
Why?
|
| Receptors, GABA | 1 | 2014 | 313 | 0.100 |
Why?
|
| Organophosphorus Compounds | 1 | 2013 | 206 | 0.100 |
Why?
|
| Stress, Psychological | 3 | 2022 | 4477 | 0.090 |
Why?
|
| Antidepressive Agents | 1 | 2003 | 2897 | 0.090 |
Why?
|
| Cocaine | 3 | 2002 | 958 | 0.090 |
Why?
|
| Opioid-Related Disorders | 4 | 2007 | 2160 | 0.090 |
Why?
|
| Health Status | 1 | 2003 | 4075 | 0.090 |
Why?
|
| Antipsychotic Agents | 2 | 2019 | 3067 | 0.090 |
Why?
|
| Choline | 1 | 2011 | 514 | 0.080 |
Why?
|
| Family | 2 | 2010 | 3197 | 0.080 |
Why?
|
| Behavior, Animal | 3 | 2002 | 1878 | 0.080 |
Why?
|
| User-Computer Interface | 1 | 2014 | 1399 | 0.080 |
Why?
|
| Public Policy | 1 | 2012 | 559 | 0.070 |
Why?
|
| Suicidal Ideation | 1 | 2018 | 1444 | 0.070 |
Why?
|
| Adenosine Triphosphate | 2 | 2004 | 1989 | 0.070 |
Why?
|
| Nootropic Agents | 1 | 2008 | 157 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 26108 | 0.070 |
Why?
|
| Body Temperature | 2 | 2001 | 782 | 0.070 |
Why?
|
| Reaction Time | 1 | 2014 | 2080 | 0.070 |
Why?
|
| Mental Health | 1 | 2021 | 3248 | 0.070 |
Why?
|
| Bipolar Disorder | 2 | 2019 | 5091 | 0.070 |
Why?
|
| Anisotropy | 2 | 2011 | 1283 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 1879 | 0.070 |
Why?
|
| Visual Perception | 1 | 2014 | 1385 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2004 | 4013 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2011 | 6019 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2019 | 5078 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 2 | 2006 | 2727 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2358 | 0.060 |
Why?
|
| Animals, Suckling | 2 | 2001 | 69 | 0.060 |
Why?
|
| Vocabulary | 1 | 2005 | 165 | 0.060 |
Why?
|
| Cycloserine | 1 | 2005 | 118 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 1791 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2002 | 2508 | 0.060 |
Why?
|
| Middle Aged | 15 | 2020 | 220774 | 0.050 |
Why?
|
| Caudate Nucleus | 1 | 2004 | 389 | 0.050 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 623 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 2399 | 0.050 |
Why?
|
| Intelligence Tests | 1 | 2004 | 503 | 0.050 |
Why?
|
| Animals | 14 | 2020 | 168388 | 0.050 |
Why?
|
| Muscimol | 1 | 2002 | 70 | 0.050 |
Why?
|
| Demyelinating Diseases | 1 | 2004 | 351 | 0.050 |
Why?
|
| Substance Abuse Detection | 1 | 2004 | 301 | 0.050 |
Why?
|
| Caregivers | 1 | 2014 | 2235 | 0.050 |
Why?
|
| Phospholipids | 1 | 2004 | 786 | 0.050 |
Why?
|
| Swimming | 1 | 2001 | 208 | 0.040 |
Why?
|
| Reflex | 1 | 2002 | 376 | 0.040 |
Why?
|
| Speech | 1 | 2005 | 554 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2021 | 64645 | 0.040 |
Why?
|
| Time Factors | 4 | 2019 | 39974 | 0.040 |
Why?
|
| Dissociative Disorders | 1 | 2021 | 234 | 0.040 |
Why?
|
| Intelligence | 1 | 2004 | 924 | 0.040 |
Why?
|
| Rodentia | 1 | 2020 | 262 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2001 | 368 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 54405 | 0.040 |
Why?
|
| Quality of Life | 1 | 2019 | 13355 | 0.040 |
Why?
|
| Lactation | 1 | 2000 | 397 | 0.040 |
Why?
|
| Dopamine | 1 | 2004 | 1605 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2007 | 2690 | 0.030 |
Why?
|
| Affect | 1 | 2004 | 1485 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 4850 | 0.030 |
Why?
|
| Heart Rate | 2 | 2004 | 4197 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2014 | 6839 | 0.030 |
Why?
|
| Kinetics | 1 | 2001 | 6374 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2004 | 2884 | 0.030 |
Why?
|
| Glycerylphosphorylcholine | 1 | 2013 | 25 | 0.030 |
Why?
|
| Reward | 1 | 2020 | 971 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2013 | 129 | 0.030 |
Why?
|
| Ethanolamines | 1 | 2013 | 152 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2013 | 153 | 0.030 |
Why?
|
| Arousal | 1 | 1998 | 1166 | 0.030 |
Why?
|
| Environment | 1 | 1998 | 1122 | 0.020 |
Why?
|
| Wakefulness | 1 | 1998 | 1265 | 0.020 |
Why?
|
| Functional Laterality | 2 | 2008 | 2256 | 0.020 |
Why?
|
| Body Weight | 1 | 2001 | 4614 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39108 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2021 | 3057 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2000 | 2630 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2007 | 1988 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2004 | 8485 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2002 | 2947 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8470 | 0.020 |
Why?
|
| Models, Biological | 1 | 2003 | 9468 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15835 | 0.020 |
Why?
|
| Color Perception | 1 | 2007 | 213 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2005 | 6937 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 3303 | 0.010 |
Why?
|
| United States | 1 | 2012 | 72317 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2490 | 0.010 |
Why?
|
| Verbal Behavior | 1 | 2005 | 335 | 0.010 |
Why?
|
| Reading | 1 | 2007 | 529 | 0.010 |
Why?
|
| Pregnancy | 5 | 2002 | 29858 | 0.010 |
Why?
|
| Gadolinium | 1 | 2006 | 960 | 0.010 |
Why?
|
| Bottle Feeding | 1 | 2001 | 67 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 680 | 0.010 |
Why?
|
| Aged | 3 | 2019 | 169179 | 0.010 |
Why?
|
| Cerebellum | 1 | 2006 | 1500 | 0.010 |
Why?
|
| Axons | 1 | 2005 | 1674 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 6309 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 3356 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 13251 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14665 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2006 | 9319 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15262 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2005 | 12329 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 10498 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 58946 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 18234 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2002 | 80575 | 0.000 |
Why?
|
Concepts
(233)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_